Header Logo

Connection

RAJENDER APARASU to Aged

Back to Details
This is a "connection" page, showing publications RAJENDER APARASU has written about Aged.
RAJENDER APARASU
Connection Strength
2.826
Aged
  1. Prevalence of multiple sclerosis and disease-modifying therapy use in older adults in the United States, 2011-2021. Mult Scler. 2025 Nov; 31(13):1595-1599.
    View in: PubMed
    Score: 0.065
  2. Factors associated with initial medication adherence with first-line therapy for depression. J Affect Disord. 2025 Dec 15; 391:120004.
    View in: PubMed
    Score: 0.064
  3. Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
    View in: PubMed
    Score: 0.061
  4. Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare data. Pharmacotherapy. 2024 Oct; 44(10):782-793.
    View in: PubMed
    Score: 0.061
  5. Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer's disease. Arch Gerontol Geriatr. 2025 Jan; 128:105629.
    View in: PubMed
    Score: 0.061
  6. Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors. Drugs Aging. 2024 Apr; 41(4):339-355.
    View in: PubMed
    Score: 0.058
  7. Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study. Drugs Aging. 2022 06; 39(6):453-465.
    View in: PubMed
    Score: 0.052
  8. Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs. 2002; 16(2):99-109.
    View in: PubMed
    Score: 0.050
  9. Risk of overactive bladder associated with cholinesterase inhibitors in dementia. J Am Geriatr Soc. 2022 03; 70(3):820-830.
    View in: PubMed
    Score: 0.050
  10. Prescribing of disease modifying agents in older adults with multiple sclerosis. Mult Scler Relat Disord. 2022 Jan; 57:103308.
    View in: PubMed
    Score: 0.049
  11. Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016. Am J Cardiol. 2021 08 01; 152:168.
    View in: PubMed
    Score: 0.048
  12. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia. Drugs Aging. 2021 07; 38(7):593-602.
    View in: PubMed
    Score: 0.048
  13. Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study. Curr Med Res Opin. 2021 08; 37(8):1303-1313.
    View in: PubMed
    Score: 0.048
  14. Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study. Drugs Aging. 2021 06; 38(6):493-502.
    View in: PubMed
    Score: 0.048
  15. Prevalence and Factors Associated with Cumulative Anticholinergic Burden Among Older Long-Stay Nursing Home Residents with Overactive Bladder. Drugs Aging. 2021 04; 38(4):311-326.
    View in: PubMed
    Score: 0.047
  16. Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder. Int J Geriatr Psychiatry. 2021 05; 36(5):684-696.
    View in: PubMed
    Score: 0.046
  17. Higher Resource Utilization and Costs in Long-Term Nursing Home Residents With Overactive Bladder: A Retrospective Study of Medicare Beneficiaries. J Am Med Dir Assoc. 2021 06; 22(6):1300-1306.
    View in: PubMed
    Score: 0.046
  18. Anticholinergic medications and risk of dementia in older adults: Where are we now? Expert Opin Drug Saf. 2020 Oct; 19(10):1251-1267.
    View in: PubMed
    Score: 0.046
  19. Antimuscarinic Discontinuation in Patients with Overactive Bladder in Nursing Homes: A Retrospective Study of Medicare Beneficiaries. Adv Ther. 2020 08; 37(8):3584-3605.
    View in: PubMed
    Score: 0.045
  20. Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.
    View in: PubMed
    Score: 0.045
  21. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
    View in: PubMed
    Score: 0.045
  22. Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother. 2000 Mar; 34(3):338-46.
    View in: PubMed
    Score: 0.044
  23. Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease. Am J Geriatr Psychiatry. 2020 10; 28(10):1079-1088.
    View in: PubMed
    Score: 0.044
  24. Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study. J Gen Intern Med. 2020 07; 35(7):2084-2093.
    View in: PubMed
    Score: 0.044
  25. Risk of pneumonia associated with atypical antipsychotic use in nursing home residents with Parkinson's disease. J Psychiatr Res. 2019 10; 117:116-121.
    View in: PubMed
    Score: 0.042
  26. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression. Res Social Adm Pharm. 2020 03; 16(3):329-335.
    View in: PubMed
    Score: 0.042
  27. Psychotropic prescribing for the elderly in office-based practice. Clin Ther. 1998 May-Jun; 20(3):603-16.
    View in: PubMed
    Score: 0.039
  28. Inappropriate medication use by the elderly. S D J Med. 1998 Jan; 51(1):27-8.
    View in: PubMed
    Score: 0.038
  29. Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression. Drugs Aging. 2017 09; 34(9):691-700.
    View in: PubMed
    Score: 0.037
  30. Atypical antipsychotic prescribing in elderly patients with depression. Res Social Adm Pharm. 2018 07; 14(7):645-652.
    View in: PubMed
    Score: 0.037
  31. Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine. Pharmacotherapy. 2017 03; 37(3):287-296.
    View in: PubMed
    Score: 0.036
  32. Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression. Am J Alzheimers Dis Other Demen. 2016 12; 31(8):678-686.
    View in: PubMed
    Score: 0.035
  33. Discharge medication complexity and 30-day heart failure readmissions. Res Social Adm Pharm. 2017 Jul - Aug; 13(4):857-863.
    View in: PubMed
    Score: 0.035
  34. Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder. Drugs Aging. 2016 10; 33(10):755-763.
    View in: PubMed
    Score: 0.035
  35. Comparative risk of hip fractures in elderly nursing home patients with depression using paroxetine and other selective serotonin reuptake inhibitors. J Comp Eff Res. 2016 08; 5(5):461-73.
    View in: PubMed
    Score: 0.034
  36. Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression. J Am Geriatr Soc. 2016 07; 64(7):1492-7.
    View in: PubMed
    Score: 0.034
  37. Functional Status of Elderly Nursing Home Residents With Parkinson's Disease. J Parkinsons Dis. 2016 06 02; 6(3):617-24.
    View in: PubMed
    Score: 0.034
  38. Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US. Res Social Adm Pharm. 2017 Mar - Apr; 13(2):358-363.
    View in: PubMed
    Score: 0.034
  39. Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression. Am J Geriatr Psychiatry. 2016 06; 24(6):485-95.
    View in: PubMed
    Score: 0.033
  40. Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study. J Am Geriatr Soc. 2016 Feb; 64(2):394-400.
    View in: PubMed
    Score: 0.033
  41. Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression. Pharmacotherapy. 2016 Jan; 36(1):38-48.
    View in: PubMed
    Score: 0.033
  42. Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression. Ann Pharmacother. 2016 Feb; 50(2):96-105.
    View in: PubMed
    Score: 0.033
  43. Potentially inappropriate anticholinergic medication use in older adults with dementia. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):603-612.
    View in: PubMed
    Score: 0.033
  44. Quality of life of patients with Parkinson's disease and neurodegenerative dementia: A nationally representative study. Res Social Adm Pharm. 2016 Jul-Aug; 12(4):604-13.
    View in: PubMed
    Score: 0.033
  45. Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors. Psychiatr Serv. 2015 Dec 01; 66(12):1333-40.
    View in: PubMed
    Score: 0.032
  46. Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study. Drugs Aging. 2015 May; 32(5):379-89.
    View in: PubMed
    Score: 0.032
  47. Anticholinergic drugs and health-related quality of life in older adults with dementia. J Am Pharm Assoc (2003). 2015 May-Jun; 55(3):282-7.
    View in: PubMed
    Score: 0.032
  48. Risk of hospitalization and use of first- versus second-generation antipsychotics among nursing home residents. Psychiatr Serv. 2014 Jun 01; 65(6):781-8.
    View in: PubMed
    Score: 0.030
  49. Prevalence and determinants of anticholinergic medication use in elderly dementia patients. Drugs Aging. 2013 Oct; 30(10):837-44.
    View in: PubMed
    Score: 0.028
  50. Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study. Am J Geriatr Pharmacother. 2012 Apr; 10(2):83-94.
    View in: PubMed
    Score: 0.025
  51. Datapoints: psychotropic drug use among elderly patients in home care in the United States. Psychiatr Serv. 2012 Jan; 63(1):6.
    View in: PubMed
    Score: 0.025
  52. Drug use trends for arthritis and other rheumatic conditions and effect of patient's age on treatment choice. N C Med J. 2011 Nov-Dec; 72(6):432-8.
    View in: PubMed
    Score: 0.025
  53. Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother. 2011 Apr; 9(2):109-19.
    View in: PubMed
    Score: 0.024
  54. Risk of serious cardiac events in older adults using antipsychotic agents. Am J Geriatr Pharmacother. 2011 Apr; 9(2):120-32.
    View in: PubMed
    Score: 0.024
  55. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey. Drugs Aging. 2010 Dec 01; 27(12):987-97.
    View in: PubMed
    Score: 0.023
  56. Risk of falls and fractures in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. Drugs Aging. 2010 Oct 01; 27(10):815-29.
    View in: PubMed
    Score: 0.023
  57. Datapoints: psychotropic drug utilization among elderly nursing home residents in the United States. Psychiatr Serv. 2010 Jul; 61(7):655.
    View in: PubMed
    Score: 0.023
  58. Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. J Clin Psychiatry. 2010 Jun; 71(6):689-98.
    View in: PubMed
    Score: 0.022
  59. Off-label use of second-generation antipsychotic agents among elderly nursing home residents. Psychiatr Serv. 2010 Feb; 61(2):130-6.
    View in: PubMed
    Score: 0.022
  60. Concomitant antipsychotic prescribing in US outpatient settings. Res Social Adm Pharm. 2009 Sep; 5(3):234-41.
    View in: PubMed
    Score: 0.020
  61. Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data. Drugs Aging. 2009; 26(6):483-92.
    View in: PubMed
    Score: 0.020
  62. Antipsychotic drug use among elderly nursing home residents in the United States. Am J Geriatr Pharmacother. 2008 Oct; 6(4):187-97.
    View in: PubMed
    Score: 0.020
  63. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Am J Geriatr Pharmacother. 2008 Oct; 6(4):198-204.
    View in: PubMed
    Score: 0.020
  64. Hypertension management in outpatient visits by diabetic patients. Res Social Adm Pharm. 2008 Sep; 4(3):284-91.
    View in: PubMed
    Score: 0.020
  65. Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004. Curr Med Res Opin. 2008 Mar; 24(3):709-16.
    View in: PubMed
    Score: 0.019
  66. Clinically important potential drug-drug interactions in outpatient settings. Res Social Adm Pharm. 2007 Dec; 3(4):426-37.
    View in: PubMed
    Score: 0.019
  67. Antipsychotic utilization and expenditure trends among elderly persons. Psychiatr Serv. 2007 Nov; 58(11):1400.
    View in: PubMed
    Score: 0.019
  68. Polypharmacy trends in office visits by the elderly in the United States, 1990 and 2000. Res Social Adm Pharm. 2005 Sep; 1(3):446-59.
    View in: PubMed
    Score: 0.016
  69. Association Between Gabapentinoid Use and Changes in Claims-Based Frailty Among Long-Term Opioid Users. Drugs Aging. 2025 Jul; 42(7):633-642.
    View in: PubMed
    Score: 0.016
  70. The quality of pharmaceutical care in the elderly. S D J Med. 2004 Nov; 57(11):489-90.
    View in: PubMed
    Score: 0.015
  71. Factors associated with the use of immune checkpoint inhibitors in older adults with metastatic non-small cell lung cancer and pre-existing autoimmune disease: A SEER-Medicare study. J Geriatr Oncol. 2024 11; 15(8):102071.
    View in: PubMed
    Score: 0.015
  72. Adverse effects associated with antipsychotic use in older adults. Expert Opin Drug Saf. 2024 Sep; 23(9):1157-1171.
    View in: PubMed
    Score: 0.015
  73. Patterns of gabapentinoid use among long-term opioid users. Prev Med. 2024 Aug; 185:108046.
    View in: PubMed
    Score: 0.015
  74. Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly. Am J Geriatr Pharmacother. 2004 Jun; 2(2):102-11.
    View in: PubMed
    Score: 0.015
  75. How do we define high and low dose intensity of heart failure medications: a scoping review. BMC Cardiovasc Disord. 2023 09 27; 23(1):478.
    View in: PubMed
    Score: 0.014
  76. Outpatient opioid prescribing by Alzheimer's diagnosis among older adults with pain in United States. BMC Geriatr. 2023 08 01; 23(1):465.
    View in: PubMed
    Score: 0.014
  77. The median doses of beta-blockers among older adults with heart failure with reduced ejection fraction. J Am Geriatr Soc. 2023 10; 71(10):3322-3325.
    View in: PubMed
    Score: 0.014
  78. Psychotropic medication expenditures for community-dwelling elderly persons. Psychiatr Serv. 2003 May; 54(5):739-42.
    View in: PubMed
    Score: 0.014
  79. Psychotropic prescription use by community-dwelling elderly in the United States. J Am Geriatr Soc. 2003 May; 51(5):671-7.
    View in: PubMed
    Score: 0.014
  80. Medication Complexity Among Older Adults with HF: How Can We Assess Better? Drugs Aging. 2022 11; 39(11):851-861.
    View in: PubMed
    Score: 0.013
  81. Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes. Breast Cancer Res Treat. 2022 Oct; 195(3):421-430.
    View in: PubMed
    Score: 0.013
  82. Healthcare Expenditure Associated With Polypharmacy in Older Adults With Cardiovascular Diseases. Am J Cardiol. 2022 04 15; 169:156-158.
    View in: PubMed
    Score: 0.013
  83. Prescribing potentially inappropriate psychotropic medications to the ambulatory elderly. Arch Intern Med. 2000 Oct 09; 160(18):2825-31.
    View in: PubMed
    Score: 0.012
  84. Utilization of ambulatory care services caused by adverse effects of medications in the United States. Manag Care Interface. 2000 Apr; 13(4):70-5.
    View in: PubMed
    Score: 0.011
  85. Opioid-induced emesis among hospitalized nonsurgical patients: effect on pain and quality of life. J Pain Symptom Manage. 1999 Oct; 18(4):280-8.
    View in: PubMed
    Score: 0.011
  86. Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm. 1999 Mar 01; 56(5):433-9.
    View in: PubMed
    Score: 0.010
  87. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer. Cancer. 2019 04 01; 125(7):1155-1162.
    View in: PubMed
    Score: 0.010
  88. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease. Epidemiol Infect. 2018 07; 146(9):1101-1105.
    View in: PubMed
    Score: 0.010
  89. Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother. 1997 Jul-Aug; 31(7-8):823-9.
    View in: PubMed
    Score: 0.009
  90. Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension. J Alzheimers Dis. 2016; 49(2):423-32.
    View in: PubMed
    Score: 0.008
  91. Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure. Am J Alzheimers Dis Other Demen. 2016 08; 31(5):395-404.
    View in: PubMed
    Score: 0.008
  92. Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study. Drugs Aging. 2015 Sep; 32(9):743-54.
    View in: PubMed
    Score: 0.008
  93. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimers Dement. 2012 Sep; 8(5):437-44.
    View in: PubMed
    Score: 0.006
  94. Comparative effectiveness of different angiotensin-converting enzyme inhibitors on the risk of hospitalization in patients with heart failure. J Comp Eff Res. 2012 Mar; 1(2):195-206.
    View in: PubMed
    Score: 0.006
  95. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):233-40.
    View in: PubMed
    Score: 0.006
  96. Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure: a multiple-propensity analysis. Res Social Adm Pharm. 2012 Mar-Apr; 8(2):145-56.
    View in: PubMed
    Score: 0.006
  97. Risk factors for dementia in patients over 65 with diabetes. Int J Geriatr Psychiatry. 2011 Jul; 26(7):749-57.
    View in: PubMed
    Score: 0.006
  98. The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors. Psychiatr Serv. 2008 Oct; 59(10):1191-7.
    View in: PubMed
    Score: 0.005
  99. Factors predicting survival, changes in activity limitations, and disability in a geriatric post-stroke population. Gerontologist. 1997 Aug; 37(4):483-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.